Is local subacromial corticosteroid injection beneficial in subacromial impingement syndrome?

Basit Öğe Kaydı
dc.authoridAKARIRMAK, ZEYNEP ULKU/0000-0002-3288-3368
dc.authoridAkgun, Kenan/0000-0002-0346-1473
dc.authorwosidAKARIRMAK, ZEYNEP ÜLKÜ/AAA-3923-2020
dc.contributor.authorAkgün, K
dc.contributor.authorBirtane, M
dc.contributor.authorAkarirmak, Ü
dc.date.accessioned2024-06-12T11:15:44Z
dc.date.available2024-06-12T11:15:44Z
dc.date.issued2004
dc.departmentTrakya Üniversitesien_US
dc.description.abstractSubacromial corticosteroid injection is one of the most frequently used management tools in subacromial impingement syndrome (SIS) despite controversial reports on the efficacy. Our purpose, in this single blinded, randomised and controlled study was to clarify whether the corticosteroid injection provides additional benefit when used with other conservative treatment modalities in 48 patients with stage 2 SIS. The patients were randomly divided into three groups according to the two therapeutic injections applied with a 10-day interval: group 1: 10 cc of 1% lignocaine + 40 mg of methylprednisolone for the first and second injections, group 2: 10 cc of 1% lignocaine + 40 mg of methylprednisolone for the first injection and only 10 cc of 1% lignocaine for the second injection, group 3: only 10 cc of 1% lignocaine for the first and second injections. All the patients were prescribed 500 mg of naproxen sodium to use two times daily, instructed to rest and perform Codman's pendulum exercises during the first 15 days. Shoulder pain during rest, activity, and causing disturbance of sleep was evaluated using a visual analogue scale and shoulder function was investigated by total Constant score and its subsectional parameters which are pain, daily living activities, active range of motion and strength before the therapy and 1 and 3 months after the therapy onset. Significant improvements from the baseline values in all pain and function parameters were observed at the first and second evaluation in all groups. Group 1 patients had more favourably improved values in pain causing sleep disturbance and daily living activity parameters than group 2 and 3 patients only in the 1st month after therapy onset. We found that subacromial corticosteroid injections in the acute or subacute phase of SIS provided additional short-term benefit without any complication when used together with nonsteroidal anti-inflammatory drugs ( NSAIDs) and exercise.en_US
dc.identifier.doi10.1007/s10067-004-0930-7
dc.identifier.endpage500en_US
dc.identifier.issn0770-3198
dc.identifier.issn1434-9949
dc.identifier.issue6en_US
dc.identifier.pmid15278758en_US
dc.identifier.scopus2-s2.0-9444222040en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage496en_US
dc.identifier.urihttps://doi.org/10.1007/s10067-004-0930-7
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24056
dc.identifier.volume23en_US
dc.identifier.wosWOS:000225304600004en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofClinical Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSubacromial Corticosteroid Injectionen_US
dc.subjectSubacromial Impingement Syndromeen_US
dc.subjectRotator Cuff Tearsen_US
dc.subjectShoulderen_US
dc.subjectMethylprednisoloneen_US
dc.subjectInterventionsen_US
dc.subjectManagementen_US
dc.subjectTendinitisen_US
dc.subjectEfficacyen_US
dc.subjectPainfulen_US
dc.subjectRatsen_US
dc.titleIs local subacromial corticosteroid injection beneficial in subacromial impingement syndrome?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu